Literature DB >> 21950406

Periprandial administration of inhaled iloprost: a risk factor for digestive bleeding?

Adrien Bigot, Annie-Pierre Jonville-Bera, Elisabeth Diot, Pascal Magro, Patrice Diot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21950406      PMCID： PMC3370355          DOI： 10.1111/j.1365-2125.2011.04105.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.

Authors:  Horst Olschewski; Beate Rohde; Jürgen Behr; Ralph Ewert; Tobias Gessler; H Ardeschir Ghofrani; Thomas Schmehl
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

2.  Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock.

Authors:  P Kiefer; I Tugtekin; H Wiedeck; H Bracht; J Vogt; U Wachter; M Weiss; C Altin; M Georgieff; P Radermacher
Journal:  Intensive Care Med       Date:  2001-07       Impact factor: 17.440

3.  Prostaglandins inhibit secretion of histamine and pancreastatin from isolated rat stomach ECL cells.

Authors:  E Lindström; R Håkanson
Journal:  Br J Pharmacol       Date:  1998-07       Impact factor: 8.739

Review 4.  Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Authors:  S M Grant; K L Goa
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.